Kaci Newlin
Nurse Practitioner · Knoxville, TNNPI 1194333849
Payments from drug & device makers
Across 319 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$919
- Amgen$809
- Vifor Pharma, Inc.$709
- Mallinckrodt Hospital Products Inc.$677
- Bayer$459
- Novartis$373
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,13498%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 51 | $919 |
| Amgen(2 entities) | 41 | $809 |
| Vifor Pharma, Inc. | 28 | $709 |
| Mallinckrodt Hospital Products Inc. | 31 | $677 |
| Bayer | 30 | $459 |
| Novartis | 19 | $373 |
| Otsuka America Pharmaceutical, Inc. | 19 | $351 |
| Calliditas Therapeutics US Inc. | 11 | $273 |
| Aurinia Pharma U.S., Inc. | 16 | $268 |
| Travere Therapeutics, Inc. | 16 | $246 |
| Fresenius USA Marketing, Inc. | 9 | $167 |
| Akebia Therapeutics Inc | 8 | $149 |
| Daiichi Sankyo Inc. | 6 | $137 |
| Sanofi | 3 | $106 |
| Alnylam Pharmaceuticals Inc. | 4 | $90 |
| ANI Pharmaceuticals, Inc. | 4 | $78 |
| Johnson & Johnson | 3 | $76 |
| OPKO Pharmaceuticals, LLC | 4 | $70 |
| Kyowa Kirin, Inc. | 4 | $67 |
| Apellis Pharmaceuticals, Inc. | 2 | $46 |
| GSK | 2 | $37 |
| Ardelyx, Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $33 |
| Pharmacosmos Therapeutics Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veltassa$119
How this compares
$6,233 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VeltassaPatiromer Calcium Sorbitex | 12 | $27,812 |
| JardianceEmpagliflozin | 11 | $11,526 |
| Bumetanide | 28 | $2,059 |
| Calcitriol | 168 | $1,266 |
| Cinacalcet Hcl | 26 | $1,169 |
| Potassium Chloride | 27 | $1,083 |
| Carvedilol | 78 | $664 |
| Chlorthalidone | 31 | $609 |
| Torsemide | 23 | $414 |
| Furosemide | 76 | $335 |
| Spironolactone | 22 | $329 |
| Hydralazine Hcl | 19 | $314 |
| Nifedipine ErNifedipine | 15 | $296 |
| Losartan Potassium | 24 | $280 |
| Allopurinol | 27 | $242 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Knoxville
- Karen RodenKnoxville$265K
- Erica HembreeKnoxville$125K
- Robin LovedayKnoxville$56K
- Tiffany SteelmanKnoxville$21K
- Jennifer BerryKnoxville$19K
- Erica HillKnoxville$13K
- Amy HatcherMurfreesboro$1.1M
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Brooke FaughtNashville$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.